Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria.

Merchant ML, Perkins BA, Boratyn GM, Ficociello LH, Wilkey DW, Barati MT, Bertram CC, Page GP, Rovin BH, Warram JH, Krolewski AS, Klein JB.

J Am Soc Nephrol. 2009 Sep;20(9):2065-74. doi: 10.1681/ASN.2008121233. Epub 2009 Jul 30.

2.

Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes.

Merchant ML, Niewczas MA, Ficociello LH, Lukenbill JA, Wilkey DW, Li M, Khundmiri SJ, Warram JH, Krolewski AS, Klein JB.

Kidney Int. 2013 Jun;83(6):1177-84. doi: 10.1038/ki.2013.8. Epub 2013 Mar 6.

3.

Discovery and verification of urinary peptides in type 2 diabetes mellitus with kidney injury.

Fu G, Du Y, Chu L, Zhang M.

Exp Biol Med (Maywood). 2016 Jun;241(11):1186-94. doi: 10.1177/1535370216629007. Epub 2016 Feb 3.

4.

Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics.

Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2008 Apr;19(4):789-97. doi: 10.1681/ASN.2007050556. Epub 2008 Feb 6.

5.

Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.

Satirapoj B, Tassanasorn S, Charoenpitakchai M, Supasyndh O.

PLoS One. 2015 Apr 17;10(4):e0124055. doi: 10.1371/journal.pone.0124055. eCollection 2015.

6.

The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes.

Drummond K, Mauer M; International Diabetic Nephropathy Study Group.

Diabetes. 2002 May;51(5):1580-7.

7.

Urinary proteomics in diabetes and CKD.

Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P; PREDICTIONS Network.

J Am Soc Nephrol. 2008 Jul;19(7):1283-90. doi: 10.1681/ASN.2007091025. Epub 2008 Apr 30.

8.

Changes in urine proteome accompanying diabetic nephropathy progression.

Lewandowicz A, Bakun M, Kohutnicki R, Fabijańska A, Kistowski M, Imiela J, Dadlez M.

Pol Arch Med Wewn. 2015;125(1-2):27-38. Epub 2015 Jan 12.

9.

Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.

Bhensdadia NM, Hunt KJ, Lopes-Virella MF, Michael Tucker J, Mataria MR, Alge JL, Neely BA, Janech MG, Arthur JM; Veterans Affairs Diabetes Trial (VADT) study group.

Kidney Int. 2013 Jun;83(6):1136-43. doi: 10.1038/ki.2013.57. Epub 2013 Mar 27.

10.

Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline.

Wanic K, Krolewski B, Ju W, Placha G, Niewczas MA, Walker W, Warram JH, Kretzler M, Krolewski AS.

PLoS One. 2013;8(3):e57751. doi: 10.1371/journal.pone.0057751. Epub 2013 Mar 7.

11.

Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes.

Perkins BA, Rabbani N, Weston A, Ficociello LH, Adaikalakoteswari A, Niewczas M, Warram J, Krolewski AS, Thornalley P.

PLoS One. 2012;7(4):e35655. doi: 10.1371/journal.pone.0035655. Epub 2012 Apr 25.

12.

Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.

Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2007 Apr;18(4):1353-61. Epub 2007 Feb 28.

13.

Early nephropathy in type 1 diabetes: the importance of early renal function decline.

Perkins BA, Krolewski AS.

Curr Opin Nephrol Hypertens. 2009 May;18(3):233-40. doi: 10.1097/MNH.0b013e3283293db1. Review.

14.

Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.

Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y.

Diabetes Metab Res Rev. 2009 Mar;25(3):232-41. doi: 10.1002/dmrr.940.

PMID:
19177462
15.

Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.

Krolewski AS.

Diabetes Care. 2015 Jun;38(6):954-62. doi: 10.2337/dc15-0184. Review.

16.

Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes.

Schlatzer D, Maahs DM, Chance MR, Dazard JE, Li X, Hazlett F, Rewers M, Snell-Bergeon JK.

Diabetes Care. 2012 Mar;35(3):549-55. doi: 10.2337/dc11-1491. Epub 2012 Jan 11.

17.

Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress.

Perkins BA, Krolewski AS.

Curr Diab Rep. 2005 Dec;5(6):455-63. Review.

PMID:
16316598
18.

Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.

Andrésdóttir G, Bakker SJ, Hansen HP, Parving HH, Rossing P.

Diabet Med. 2013 May;30(5):563-6. doi: 10.1111/dme.12131. Epub 2013 Mar 7.

PMID:
23324103
19.

'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'.

MacIsaac RJ, Ekinci EI, Jerums G.

Kidney Int. 2014 Jul;86(1):50-7. doi: 10.1038/ki.2014.98. Epub 2014 Apr 9. Review.

PMID:
24717301
20.

Renal lesions predict progression of diabetic nephropathy in type 1 diabetes.

Caramori ML, Parks A, Mauer M.

J Am Soc Nephrol. 2013 Jun;24(7):1175-81. doi: 10.1681/ASN.2012070739. Epub 2013 May 16.

Supplemental Content

Support Center